3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine(CAS: 1229236-86-5)

The compound is a solid with a crystalline form. Its molecular weight is approximately 600 g/mol. It has low water solubility but good solubility in organic solvents like DMSO. Reactivity is moderate with typical inorganic acids. It is stable under normal storage conditions but should be protected from moisture and light.

The compound is synthesized via a multi-step process involving the functionalization of a benzyl chloride, followed by coupling reactions with a pyrazole derivative and morpholine. Commonly used catalysts include Pd(PPh3)4 and HATU. The overall yield is around 50-60%, with high selectivity for the desired product.

This compound finds applications in the pharmaceutical industry as an intermediate in the synthesis of bioactive compounds. It is also of interest in the chemical industry for its reactivity and potential use in developing new materials and sensors.

Proper personal protective equipment (PPE) including gloves, goggles, and lab coat should be worn. Work should be conducted in a fume hood due to its potential volatility. Spills should be cleaned up immediately with appropriate absorbents. Refer to the Safety Data Sheet (SDS) for detailed guidelines on handling and storage.